AC Immune (ACIU) Cash from Investing Activities Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57.27% |
| Sep 30, 2025 | 90.04% |
| Jun 30, 2025 | 4.33% |
| Mar 31, 2025 | 97.98% |
| Dec 31, 2024 | 42.98% |
| Sep 30, 2024 | -64.71% |
| Jun 30, 2024 | -35.61% |
| Mar 31, 2024 | -213.77% |
| Dec 31, 2023 | 78.58% |
| Sep 30, 2023 | -30.65% |
| Jun 30, 2023 | -37.05% |
| Mar 31, 2023 | 497.33% |
| Dec 31, 2022 | 42.82% |
| Sep 30, 2022 | 20.65% |
| Jun 30, 2022 | 325.68% |
| Mar 31, 2022 | 77.41% |
| Dec 31, 2021 | 8.22% |
| Sep 30, 2021 | -56.27% |
| Jun 30, 2021 | -332.16% |
| Mar 31, 2021 | 10.61% |
| Dec 31, 2020 | -86.46% |
| Sep 30, 2020 | 26.17% |
| Jun 30, 2020 | 133.08% |
| Mar 31, 2020 | 29.98% |
| Dec 31, 2019 | -170.10% |
| Sep 30, 2019 | -223.43% |
| Jun 30, 2019 | -50.10% |
| Mar 31, 2019 | -521.31% |
| Dec 31, 2018 | -1,720.27% |